Summary & Overview
HCPCS G9695: Long-Acting Inhaled Bronchodilator Prescribed
HCPCS Level II code G9695 denotes the prescription of a long-acting inhaled bronchodilator, a commonly used therapeutic intervention for chronic obstructive airway conditions. National attention to this code reflects the clinical importance of maintenance bronchodilator therapy for patients with chronic respiratory disease and the billing implications for outpatient and pharmacy encounters. The code captures the episode when a long-acting inhaled bronchodilator is prescribed, supporting claims for medication management and related clinical services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how G9695 is used in practice, typical sites of service, and the clinical context for long-acting inhaled bronchodilator therapy. The publication also provides operational benchmarks and coding considerations relevant to billing staff, revenue cycle leaders, and clinical managers, along with notes on common modifiers and ancillary documentation needs where available. Data not available in the input is explicitly identified in relevant sections.
Billing Code Overview
HCPCS Level II code G9695 indicates a long-acting inhaled bronchodilator prescribed. This service represents the prescription and related clinical encounter for initiation or continuation of a long-acting inhaled bronchodilator therapy intended for chronic obstructive airway management.
-
Service type: Prescription and medication management for a long-acting inhaled bronchodilator
-
Typical site of service: Outpatient clinic, ambulatory care, or pharmacy setting where the prescription is issued or managed
Clinical & Coding Specifications
Clinical Context
A patient with chronic obstructive pulmonary disease (COPD) or moderate-to-severe persistent asthma presents to an outpatient pulmonary clinic or primary care office for management of chronic airflow obstruction and symptom control. The clinician documents ongoing dyspnea, exertional limitation, and frequent rescue inhaler use despite short-acting bronchodilators. Spirometry demonstrates airflow obstruction or a history supports long-acting bronchodilator therapy. The clinician prescribes a long-acting inhaled bronchodilator (maintenance therapy) and provides education on device technique, adherence, and follow-up. Typical sites of service include outpatient clinics, pulmonary specialty offices, federally qualified health centers, and occasionally home health visits when the medication is initiated or technique assessment is required. The clinical workflow includes evaluation (history and exam), review of prior inhaler therapy and adherence, assessment of inhaler technique, prescription of the long-acting agent, documentation of indications and severity, and arrangement of follow-up or referral for pulmonary rehabilitation as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work beyond the typical service is documented (e.g., extensive education or complex medication reconciliation). |